Abortion


"KFF graphic with white text on a purple background that reads "Interactive Dashboard: Abortion in the United States." The graphic also has photo illustrations of the Supreme Court and abortion medication."

The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →


Filter

91 - 100 of 278 Results

  • Supreme Court Cases on Content Moderation and Mifepristone Access — The Monitor

    Feature

    This issue of the Monitor focuses on recent Supreme Court decisions impacting health misinformation. We examine cases balancing free speech and platform regulation, the Court’s ruling on mifepristone access and public perceptions of social media moderation. We also explore COVID-19 narratives after Dr. Fauci’s congressional testimony and AI developments in predicting misinformation trends during pandemics.

  • Raw Milk Myths, Vaccine Falsehoods, and Reproductive Health Narratives – The Monitor

    Feature

    This first edition of the Health Misinformation Monitor explores misinformation about raw milk amid bird flu outbreaks on dairy farms, false vaccine narratives that continue to spread, and legal challenges against abortion pill reversal claims. Additionally, a growing number of states have required public schools to show fetal development videos that some have called biased and inaccurate. This Monitor report also provides a snapshot of new KFF misinformation polling on TikTok and discusses the early challenges faced by The World Health Organization’s new AI tool SARAH in providing accurate answers to health questions.

  • Emergency Abortion Care to Preserve the Health of Pregnant People: SCOTUS, EMTALA, and Beyond

    Policy Watch

    This policy watch outlines SCOTUS' June 27, 2024, decision dismissing the case, Moyle v. United States, where the Court had been asked to determine if a federal law called the Emergency Medical Treatment and Labor Act preempted Idaho's abortion ban. The decision returns the case to the lower courts and reinstates a court order blocking enforcement of the Idaho ban where it prohibits abortion care for pregnant people having medical emergencies.

  • Polling Insight: 4 Takeaways About Suburban Women Voters

    Poll Finding

    This Polling Insight explores the demographic makeup, issue priorities, and sentiment toward presidential candidates of women voters living in suburban areas leading up to the election this fall.

  • Unraveling the Mysteries of Biden vs. Trump on Health Care

    From Drew Altman

    In his latest column, KFF President and CEO Drew Altman unravels the differences between Trump and Biden on Medicare, abortion, drug costs and other health-related issues that KFF's new side-by-side candidate analysis examines. From the bird’s eye view, these differences amount to a fork in the road in direction on the role of the federal government in health and federal health spending.

  • Criminal Penalties for Physicians in State Abortion Bans

    Issue Brief

    This brief examines the legal considerations for physicians providing abortion care, including criminal and professional penalties, as well as the potential for medical malpractice lawsuits for delayed care to patients due to bans and prosecution for violation of abortion bans across state lines.

  • Abortion Trends Before and After Dobbs

    Issue Brief

    This brief reviews the different sources of abortion data in the United States, the factors that have affected abortion rates across the U.S, before and after Roe v. Wade, and what we may see as the Trump administration, Republican majorities in the House and Senate, and a conservative federal judiciary shape policy in the coming years.

  • The Outlook for PEPFAR in 2025 and Beyond

    Policy Watch

    PEPFAR, the U.S. global HIV/AIDS program, is - for the first time in its two-decade history - facing significant challenges that could impede its ability to fulfill its mission. This policy brief provides an overview of recent events and ongoing challenges facing the program.

  • States Expand Access to Ivermectin as Cancer Myths Continue, and Abortion Pill Faces False Water Supply Claim — The Monitor

    Feature

    This volume examines unsupported claims about ivermectin; the promotion of unproven “detox” supplements in response to falsehoods about the spike protein from the COVID-19 virus and vaccine; the unsubstantiated claim that byproducts from medication abortion pills contaminate the water supply; and the renewed debate over ADHD diagnoses and treatments.